Literature DB >> 1774340

Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR.

C L Hyman1, M H Augenbraun, P M Roblin, J Schachter, M R Hammerschlag.   

Abstract

Chlamydia pneumoniae is a newly recognized organism associated with respiratory tract infections. Asymptomatic infection with C. pneumoniae, although it has been suggested to occur, has not been previously documented. We describe two asymptomatic individuals infected with this organism; these infections demonstrate that C. pneumoniae is able to establish a subclinical infection.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1774340      PMCID： PMC270268          DOI： 10.1128/jcm.29.9.2082-2083.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

Authors:  K Chirgwin; P M Roblin; M R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Experimental infection with Chlamydia pneumoniae in nonhuman primates.

Authors:  S M Holland; H R Taylor; C A Gaydos; E W Kappus; T C Quinn
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically.

Authors:  J T Grayston; V K Diwan; M Cooney; S P Wang
Journal:  Arch Intern Med       Date:  1989-01

4.  Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland.

Authors:  M Kleemola; P Saikku; R Visakorpi; S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

5.  Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys.

Authors:  M A Shafer; V Prager; J Shalwitz; E Vaughan; B Moscicki; R Brown; C Wibbelsman; J Schachter
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

6.  Screening for chlamydial infections in women attending family planning clinics.

Authors:  J Schachter; E Stoner; J Moncada
Journal:  West J Med       Date:  1983-03

7.  Infection with Chlamydia pneumoniae in Brooklyn.

Authors:  K Chirgwin; P M Roblin; M Gelling; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

Review 8.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

9.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245
  9 in total
  15 in total

1.  Laboratory diagnosis of Chlamydia pneumoniae infections.

Authors:  R W Peeling
Journal:  Can J Infect Dis       Date:  1995-07

2.  Limited utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of respiratory tract infections.

Authors:  Rosemary C She; Andy Thurber; Weston C Hymas; Jeffery Stevenson; Janine Langer; Christine M Litwin; Cathy A Petti
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

3.  Chlamydia pneumoniae.

Authors:  T J Marrie
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

Review 4.  Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.

Authors:  M R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

5.  Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene.

Authors:  G Wagels; S Rasmussen; P Timms
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

6.  High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection.

Authors:  Matheus Silva Alves; Marilha da Silva Cariolano; Hivylla Lorrana Dos Santos Ferreira; Elen Sousa de Abreu Silva; Karen Karollynny Pereira Felipe; Silvio Gomes Monteiro; Eduardo Martins de Sousa; Afonso Gomes Abreu; Lee Ann Campbell; Michael E Rosenfeld; Mario Hiroyuki Hirata; Rosario Dominguez Crespo Hirata; Gisele Medeiros Bastos; Ilana Cristina de Paula Abreu Silva; Lidio Gonçalves Lima-Neto
Journal:  Braz J Microbiol       Date:  2020-01-30       Impact factor: 2.476

7.  Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.

Authors:  U V Comandini; P Maggi; P Santopadre; R Monno; G Angarano; V Vullo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

8.  Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells.

Authors:  J J Theunissen; B Y van Heijst; J H Wagenvoort; E Stolz; M F Michel
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

9.  Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols.

Authors:  H J Theunissen; N A Lemmens-den Toom; A Burggraaf; E Stolz; M F Michel
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

10.  Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.

Authors:  R P Verkooyen; D Willemse; S C Hiep-van Casteren; S A Joulandan; R J Snijder; J M van den Bosch; H P van Helden; M F Peeters; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.